These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 24620626)

  • 21. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy.
    Weinstock LB; Fern SE; Duntley SP
    Dig Dis Sci; 2008 May; 53(5):1252-6. PubMed ID: 17934858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.
    Majewski M; Reddymasu SC; Sostarich S; Foran P; McCallum RW
    Am J Med Sci; 2007 May; 333(5):266-70. PubMed ID: 17505166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifaximin: The Revolutionary Antibiotic Approach for Irritable Bowel Syndrome.
    Triantafyllou K; Sioulas AD; Giamarellos-Bourboulis EJ
    Mini Rev Med Chem; 2015; 16(3):186-92. PubMed ID: 26202193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC; Nehra A; Mathur A; Rai S
    J Gastroenterol Hepatol; 2020 Jun; 35(6):922-931. PubMed ID: 31750966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
    Furnari M; Parodi A; Gemignani L; Giannini EG; Marenco S; Savarino E; Assandri L; Fazio V; Bonfanti D; Inferrera S; Savarino V
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1000-6. PubMed ID: 20937045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
    Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
    Petrone P; Sarkisyan G; Fernández M; Coloma E; Akopian G; Ortega A; Kaufman HS
    Arch Surg; 2011 Apr; 146(4):444-7. PubMed ID: 21502453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
    Meyrat P; Safroneeva E; Schoepfer AM
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1084-93. PubMed ID: 23066911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
    Lauritano EC; Gabrielli M; Scarpellini E; Ojetti V; Roccarina D; Villita A; Fiore E; Flore R; Santoliquido A; Tondi P; Gasbarrini G; Ghirlanda G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009; 13(2):111-6. PubMed ID: 19499846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose hydrogen breath test for small intestinal bacterial overgrowth in children with abdominal pain-related functional gastrointestinal disorders.
    Korterink JJ; Benninga MA; van Wering HM; Deckers-Kocken JM
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):498-502. PubMed ID: 25406525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.
    Scarpellini E; Gabrielli M; Lauritano CE; Lupascu A; Merra G; Cammarota G; Cazzato IA; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2007 Apr; 25(7):781-6. PubMed ID: 17373916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.
    Bae S; Lee KJ; Kim YS; Kim KN
    J Korean Med Sci; 2015 Jun; 30(6):757-62. PubMed ID: 26028929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
    Pimentel M
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():37-49. PubMed ID: 26618924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total Bilirubin Is Associated with Small Intestinal Bacterial Overgrowth in Diarrhea Predominant Irritable Bowel Syndrome.
    Kim SY; Seo YS; Lee ES; Kim KN
    Ann Clin Lab Sci; 2019 May; 49(3):344-352. PubMed ID: 31308034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.
    Boltin D; Perets TT; Shporn E; Aizic S; Levy S; Niv Y; Dickman R
    Ann Clin Microbiol Antimicrob; 2014 Oct; 13():49. PubMed ID: 25319626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid Thyroxine Improves Outcomes in Hypothyroid Patients With Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome.
    Henderson BB; Smith SP; Mengelkamp ME; Rhymer EK; Gray KN; Jackson AG; Henry SF; Chuang S; Stavrakas EH; Blair OM; Heaps M
    Endocr Pract; 2024 Jun; 30(6):505-512. PubMed ID: 38490469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1.
    Pimentel M
    Am J Gastroenterol; 2010 Apr; 105(4):718-21. PubMed ID: 20372119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
    Scarpellini E; Giorgio V; Gabrielli M; Lauritano EC; Pantanella A; Fundarò C; Gasbarrini A
    J Pediatr; 2009 Sep; 155(3):416-20. PubMed ID: 19535093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.